These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
608 related items for PubMed ID: 30029480
1. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth. Bothwell PJ, Kron CD, Wittke EF, Czerniak BN, Bode BP. Int J Mol Sci; 2018 Jul 19; 19(7):. PubMed ID: 30029480 [Abstract] [Full Text] [Related]
2. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutté E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J. J Biol Chem; 2018 Feb 23; 293(8):2877-2887. PubMed ID: 29326164 [Abstract] [Full Text] [Related]
3. Targeting glutamine transport to suppress melanoma cell growth. Wang Q, Beaumont KA, Otte NJ, Font J, Bailey CG, van Geldermalsen M, Sharp DM, Tiffen JC, Ryan RM, Jormakka M, Haass NK, Rasko JE, Holst J. Int J Cancer; 2014 Sep 01; 135(5):1060-71. PubMed ID: 24531984 [Abstract] [Full Text] [Related]
4. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Fuchs BC, Finger RE, Onan MC, Bode BP. Am J Physiol Cell Physiol; 2007 Jul 01; 293(1):C55-63. PubMed ID: 17329400 [Abstract] [Full Text] [Related]
5. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Fuchs BC, Bode BP. Semin Cancer Biol; 2005 Aug 01; 15(4):254-66. PubMed ID: 15916903 [Abstract] [Full Text] [Related]
6. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2. Yang Z, Follett J, Kerr MC, Clairfeuille T, Chandra M, Collins BM, Teasdale RD. J Biol Chem; 2018 May 04; 293(18):6802-6811. PubMed ID: 29563155 [Abstract] [Full Text] [Related]
7. Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells. Polet F, Martherus R, Corbet C, Pinto A, Feron O. Oncotarget; 2016 Jul 19; 7(29):46371-46383. PubMed ID: 27344174 [Abstract] [Full Text] [Related]
8. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. van Geldermalsen M, Wang Q, Nagarajah R, Marshall AD, Thoeng A, Gao D, Ritchie W, Feng Y, Bailey CG, Deng N, Harvey K, Beith JM, Selinger CI, O'Toole SA, Rasko JE, Holst J. Oncogene; 2016 Jun 16; 35(24):3201-8. PubMed ID: 26455325 [Abstract] [Full Text] [Related]
9. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. Zhang Z, Liu R, Shuai Y, Huang Y, Jin R, Wang X, Luo J. Br J Cancer; 2020 Jan 16; 122(1):82-93. PubMed ID: 31819178 [Abstract] [Full Text] [Related]
10. LncRNA SLC1A5-AS/MZF1/ASCT2 Axis Contributes to Malignant Progression of Hepatocellular Carcinoma. Jiang J, Dong W, Zhang W, Wang Q, Wang R, Wang J, Wu H, Dong H, Zhao RC, Wang J, Li Z. Discov Med; 2023 Dec 16; 35(179):995-1014. PubMed ID: 38058065 [Abstract] [Full Text] [Related]
11. Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells. Bröer A, Gauthier-Coles G, Rahimi F, van Geldermalsen M, Dorsch D, Wegener A, Holst J, Bröer S. J Biol Chem; 2019 Mar 15; 294(11):4012-4026. PubMed ID: 30635397 [Abstract] [Full Text] [Related]
12. Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells. Fuchs BC, Perez JC, Suetterlin JE, Chaudhry SB, Bode BP. Am J Physiol Gastrointest Liver Physiol; 2004 Mar 15; 286(3):G467-78. PubMed ID: 14563674 [Abstract] [Full Text] [Related]
13. Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells. Bröer A, Rahimi F, Bröer S. J Biol Chem; 2016 Jun 17; 291(25):13194-205. PubMed ID: 27129276 [Abstract] [Full Text] [Related]
14. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. Okudaira H, Nakanishi T, Oka S, Kobayashi M, Tamagami H, Schuster DM, Goodman MM, Shirakami Y, Tamai I, Kawai K. Nucl Med Biol; 2013 Jul 17; 40(5):670-5. PubMed ID: 23647854 [Abstract] [Full Text] [Related]
15. Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma. Honjo H, Kaira K, Miyazaki T, Yokobori T, Kanai Y, Nagamori S, Oyama T, Asao T, Kuwano H. J Surg Oncol; 2016 Mar 17; 113(4):381-9. PubMed ID: 26936531 [Abstract] [Full Text] [Related]
16. Genetic Ablation of LAT1 Inhibits Growth of Liver Cancer Cells and Downregulates mTORC1 Signaling. Kim SY, Ong Q, Liao Y, Ding Z, Tan AQL, Lim LTR, Tan HM, Lim SL, Lee QY, Han W. Int J Mol Sci; 2023 May 24; 24(11):. PubMed ID: 37298123 [Abstract] [Full Text] [Related]
17. Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma. Nikkuni O, Kaira K, Toyoda M, Shino M, Sakakura K, Takahashi K, Tominaga H, Oriuchi N, Suzuki M, Iijima M, Asao T, Nishiyama M, Nagamori S, Kanai Y, Oyama T, Chikamatsu K. Pathol Oncol Res; 2015 Sep 24; 21(4):1175-81. PubMed ID: 26024742 [Abstract] [Full Text] [Related]
18. Targeting SLC1A5 blocks cell proliferation through inhibition of mTORC1 in arsenite-treated human uroepithelial cells. Li S, Zhou Q, Liu W, Fu Z, Zhao H, Xi S. Toxicol Lett; 2021 Jul 01; 345():1-11. PubMed ID: 33781819 [Abstract] [Full Text] [Related]
19. GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma. Sun HW, Yu XJ, Wu WC, Chen J, Shi M, Zheng L, Xu J. PLoS One; 2016 Jul 01; 11(12):e0168907. PubMed ID: 28036362 [Abstract] [Full Text] [Related]
20. Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, Takayasu Y, Takahashi K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K. Br J Cancer; 2014 May 13; 110(10):2506-13. PubMed ID: 24762957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]